WALTHAM, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2022 Sustainability Report and related reporting index disclosures. Themed “Making an Impact”, the report highlights the company’s measurable progress across multiple environmental, social…Read More
Related Posts
Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. ("Finch", "Finch Therapeutics" or the "Company") (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property…
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and…
BOSTON, July 31, 2023 /PRNewswire/ -- On July 25, 2023, Fosun Health Capital established by Fosun Pharma (stock code:600196.SH), reached a strategic partnership with Medicilon (stock code: 688202.SH). Meanwhile StarMab…
Addimmune to Go Public via Merger with 10X Capital Venture Acquisition Corp III VCXB
American Gene Technologies International Inc. (âAGTâ) and 10X Capital Venture Acquisition Corp. III (â10X IIIâ) (NYSE: VCXB), a special purpose acquisition company, today announced that they have entered into a…
